Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02649777 · ClinicalTrials.gov registry record
Normal Values of Oxidative Stress, Taurine, and Related Markers
A clinical trial, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- 22
- Enrollment target
NCT02649777: Completed study, sponsored by University of Colorado, Denver.
NCT02649777 is a clinical trial that has completed, run by University of Colorado, Denver. The registered enrollment target is 22 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02649777 has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- 22 participants
- Enrollment target
Study Summary
The role of oxidative stress in disease pathology is increasingly recognized. At present, the development of biomarkers of this state is in its infancy and the availability of clinically validated assays is lacking. This study will better determine normal values for specific biomarkers of oxidative stress. It will also investigate normal values of taurine, a natural occurring oxidative stress protectant. A primary and specific application of this data is for the evaluation of oxidative stress, levels of the natural protectant taurine, and of associated inflammation in the context of cystathionine β-synthase (ClinicalTrials.gov study: Oxidative Stress Markers in Inherited Homocystinuria and the Impact of Taurine).
Primary Outcome
Single Draw for one-time analysis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2016-01 |
| Est. Completion | 2017-12 |
What the finished NCT02649777 record still lists
NCT02649777 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 22 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02649777 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02649777 about?
NCT02649777 is a clinical study titled "Normal Values of Oxidative Stress, Taurine, and Related Markers". The role of oxidative stress in disease pathology is increasingly recognized. At present, the development of biomarkers of this state is in its infancy and the availability of clinically validated assays is lacking. This study will better determine normal values for specific biomarkers of oxidative ...
What is the current status of trial NCT02649777?
This trial is currently completed. The enrollment target is 22 participants. The study started on 2016-01. Estimated completion is 2017-12.
Who is sponsoring clinical trial NCT02649777?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02508038 · 22 participants · Phase 1
Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
- NCT03099356 · 22 participants · Phase 2
Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer
- NCT03676647 · 22 participants
Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules
- NCT04569591 · 22 participants · NA
DDAVP for Pituitary Adenoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia